Studies of differences in lymphocyte and CD4+ T cell subsets between ACPA positive (ACPA+) and negative (ACPA-) RA patients, and identification of new serological markers are of great importance in the early diagnosis of ACPA- RA and in understanding its underlying pathological mechanism. Here, PRTN3 is linked to rheumatoid arthritis.